|
|
Volumn 119, Issue 11, 2012, Pages 2312-2318
|
|
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RANIBIZUMAB;
ARTICLE;
BEST CORRECTED VISUAL ACUITY;
CLINICAL EVALUATION;
CONTROLLED STUDY;
CORNEA THICKNESS;
DIABETIC MACULAR EDEMA;
DIAGNOSTIC TEST ACCURACY STUDY;
DRUG ADMINISTRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ENDOPHTHALMITIS;
EYE;
FOLLOW UP;
HUMAN;
INJECTION SITE ENDOPHTHALMITIS;
LOW LEVEL LASER THERAPY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINA FOVEA;
SCORING SYSTEM;
SNELLEN CHART;
TREATMENT DURATION;
TREATMENT RESPONSE;
VISION;
VISION TEST;
VISUAL ACUITY;
VISUAL FIELD;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
COMBINED MODALITY THERAPY;
DIABETIC RETINOPATHY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTRAVITREAL INJECTIONS;
LASER COAGULATION;
MACULAR EDEMA;
MALE;
MIDDLE AGED;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VISUAL ACUITY;
|
|
EID: 84868208071
PISSN: 01616420
EISSN: 15494713
Source Type: Journal
DOI: 10.1016/j.ophtha.2012.08.022 Document Type: Article |
|
Times cited : (346)
|
|
References (4)
|
